Pandemic Influenza: Population susceptibility, severity and spread: Rapid Research using the Health Survey for England (HSE)
Not Applicable
Completed
- Conditions
- InfluenzaInfections and Infestations
- Registration Number
- ISRCTN80214280
- Lead Sponsor
- niversity College London (UCL) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 3216
Inclusion Criteria
All participants participating in the HSE who have a household interview date between 01/10/2012 and 31/03/2013.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Influenza antibody titres - haemagglutination inhibition assay (HIA test)<br>2. Influenza-like illness - questionnaire<br><br>Measured at baseline
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What host genetic factors influence pandemic influenza susceptibility in the HSE 2014 study?
Which biomarkers correlate with severe pandemic influenza outcomes in the UCL 2014 observational study?
How does the ISRCTN80214280 study assess immune response dynamics in pandemic influenza populations?
What risk factors for severe complications are identified in the ISRCTN80214280 pandemic influenza study?
How does the 2014 HSE study compare transmission patterns between pandemic and seasonal influenza strains?